Bank of Nova Scotia’s Novo Nordisk NVO Stock Holding History

Bank of Nova Scotia’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$147M	Buy	3,065,015 +3,010,608	+5,533%	+$129M	0.22%	76
2026 Q1	$2M	Buy	54,407 +4,440	+9%	+$210K	﹤0.01%	747
2025 Q4	$2.54M	Buy	49,967 +20,793	+71%	+$1.06M	﹤0.01%	753
2025 Q3	$1.62M	Buy	29,174 +10,375	+55%	+$607K	﹤0.01%	735
2025 Q2	$1.3M	Buy	18,799 +6,630	+54%	+$451K	﹤0.01%	742
2025 Q1	$845K	Sell	12,169 -481	-4%	-$39.7K	﹤0.01%	759
2024 Q4	$1.09M	Buy	12,650 +4,866	+63%	+$526K	﹤0.01%	774
2024 Q3	$921K	Buy	+7,784	New	+$1.04M	﹤0.01%	775
2024 Q1	–	Sell	-3,987	Closed	-$411K	–	1044
2023 Q4	$411K	Buy	3,987 +1,111	+39%	+$110K	﹤0.01%	880
2023 Q3	$263K	Buy	+2,876	New	+$253K	﹤0.01%	926
2016 Q2	–	Sell	-360,000	Closed	-$9.75M	–	760
2016 Q1	$9.75M	Buy	+360,000	New	+$9.64M	0.06%	146

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of Nova Scotia's NVO Position: Q2 2026 in Review

Bank of Nova Scotia increased its Novo Nordisk (NVO) stake by 5,533% in Q2 2026, buying an estimated $129M and bringing the position to 3,065,015 shares worth $147M. The position accounts for 0.22% of the portfolio, ranked #76.

Bank of Nova Scotia first reported a position in NVO in Q1 2016 and has held it in 11 quarters since. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Bank of Nova Scotia held 3,065,015 shares of Novo Nordisk worth $147M as of Q2 2026.
Bank of Nova Scotia bought 3,010,608 Novo Nordisk shares in Q2 2026, an estimated $129M.
Novo Nordisk made up 0.22% of Bank of Nova Scotia's portfolio in Q2 2026, its #76 holding.
Bank of Nova Scotia first reported a position in Novo Nordisk in Q1 2016 and has held it in 11 quarters since.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Bank of Nova Scotia's 13F filing for Q2 2026, filed 12 Aug 2026.